Apoptosis: implications of basic research for clinical oncology

The Lancet Oncology
I TammB Dörken

Abstract

Recent studies have indicated a role for apoptosis in a variety of human diseases. Suppression of apoptosis contributes to carcinogenesis by several mechanisms, including facilitating the accumulation of gene mutations, permitting growth-factor-independent cell survival, promoting resistance to immune-based cytotoxicity, and allowing bypassing of cell-cycle checkpoints, which would normally induce apoptosis. Defects in apoptotic mechanisms also play an important part in resistance to chemotherapy and radiation. The core machinery of the cell death pathway can be reduced to a few critical types of proteins, which are well conserved across animal evolution. This review gives an update on the key players involved in apoptosis as well as an overview of the involvement of apoptosis in disease, and novel diagnostic and therapeutic options derived from the extensive basic research on this topic carried out over the last decade.

References

May 1, 1992·Immunology Today·L A Tartaglia, D V Goeddel
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J C ReedK Bradley
Jun 21, 1985·Science·Y TsujimotoC M Croce
Dec 1, 1973·The Journal of Pathology·A H WyllieA R Currie
Jan 1, 1994·Cold Spring Harbor Symposia on Quantitative Biology·H R HorvitzM O Hengartner
May 31, 1996·The Journal of Biological Chemistry·R M PittiA Ashkenazi
Feb 1, 1997·Seminars in Immunology·D K Miller
Jul 10, 1997·Nature·M IrmlerJ Tschopp
Aug 1, 1997·Nature Medicine·G AmbrosiniD C Altieri
Jan 1, 1997·British Medical Bulletin·N A Thornberry
May 9, 1998·The Journal of Biological Chemistry·R TakahashiJ C Reed
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·J M JürgensmeierJ C Reed
Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Aug 28, 1998·Science·D R Green, J C Reed
Sep 12, 1998·Science·J M Adams, S Cory
Oct 31, 1998·Current Opinion in Immunology·T S Griffith, D H Lynch
Jan 23, 1999·Current Opinion in Oncology·J C Reed
Jan 23, 1999·Oncogene·A BergmannH Steller
Jan 23, 1999·Oncogene·E C LaCasseA E MacKenzie
Feb 17, 1999·Genes & Development·Q L Deveraux, J C Reed
Mar 30, 1999·Experimental Cell Research·M Jäättelä
Apr 14, 1999·Cell Death and Differentiation·M TolomeoL Rausa
Jul 20, 1999·The Journal of Clinical Investigation·A AshkenaziR H Schwall
Aug 12, 1999·Cellular and Molecular Life Sciences : CMLS·K Hofmann
Dec 22, 1999·Biochemical and Biophysical Research Communications·B FadeelB Zhivotovsky
Jan 11, 2000·Molecular and Cellular Biology·R EskesJ C Martinou
Feb 19, 2000·Current Opinion in Genetics & Development·S PelengarisT Littlewood
Feb 25, 2000·Biologicals : Journal of the International Association of Biological Standardization·K Müller-Breitkreutz, J P Allain
Mar 31, 2000·Trends in Pharmacological Sciences·E KollerB P Monia
Apr 27, 2000·Nature Cell Biology·J W Harbour, D C Dean
May 10, 2000·Nature Medicine·S Nagata
May 17, 2000·The Journal of Experimental Medicine·M HaraguchiJ C Reed
Jun 29, 2000·Annual Review of Biochemistry·W C EarnshawS H Kaufmann

❮ Previous
Next ❯

Citations

Sep 5, 2003·Breast Cancer : the Journal of the Japanese Breast Cancer Society·A Lakshmi KesariM Radhakrishna Pillai
Dec 28, 2006·Apoptosis : an International Journal on Programmed Cell Death·J H WangB Y Chen
Dec 3, 2003·Cancer Detection and Prevention·Daniela SchlofferJózefa Wesierska-Gadek
Jun 23, 2001·BMJ : British Medical Journal·M PartonI Smith
Jun 7, 2006·Biological & Pharmaceutical Bulletin·Wei WangXiao-Tang Wang
Oct 21, 2004·Biological Chemistry·Konstantina MathioudakiMaroulio Talieri
Mar 21, 2002·The Lancet Oncology·K Campbell
Dec 24, 2005·Apoptosis : an International Journal on Programmed Cell Death·C Di PietroM Purrello
Nov 13, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Frank J P HoebersMarcel Verheij
Mar 15, 2002·Seminars in Oncology·Rafael RosellJosé Javier Sanchez
May 3, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Thiruvanmiyoor Ravichandran Kameswaran, Ravichandran Ramanibai
Oct 9, 2007·Archivos de bronconeumología·Alfredo Paredes LarioCarmen Lobo
Aug 21, 2007·Leukemia Research·Semra PaydasUmut Disel
Oct 31, 2006·Biochemical and Biophysical Research Communications·Yang HuQing-Long Guo
Feb 18, 2005·Clinical Oncology : a Journal of the Royal College of Radiologists·P HatfieldA Melcher
Sep 29, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Marina KartachovaMarcel Verheij
Jul 5, 2005·The Lancet Oncology·Kevin M PriseKathryn D Held
May 28, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Qian-Mei ZhouShi-Bing Su
Aug 23, 2011·Journal of Ethnopharmacology·Qibiao WuLing He
Jul 31, 2004·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Chiara Mondello, A Ivana Scovassi
Feb 26, 2016·International Journal of Molecular Sciences·Rodrigo Ramirez-TagleCesar Echeverria
Nov 26, 2009·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Rong MuQinglong Guo
Apr 19, 2006·International Journal of Cancer. Journal International Du Cancer·Mandy WagnerIngo Tamm
May 19, 2007·Chemistry & Biodiversity·Rusong ZhangXiaoyu Li
Jul 23, 2009·Chemistry & Biodiversity·Jun TanLiancai Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Related Papers

International Journal of Cancer. Journal International Du Cancer
T OguriN Kohno
Annals of Oncology : Official Journal of the European Society for Medical Oncology
G V ScagliottiG Selvaggi
International Journal of Radiation Oncology, Biology, Physics
M E Richardson, D W Siemann
© 2022 Meta ULC. All rights reserved